行情

NSPR

NSPR

INSPIREMD
AMEX

实时行情|Nasdaq Last Sale

1.210
-0.010
-0.82%
盘后: 1.210 0 0.00% 16:47 01/24 EST
开盘
1.220
昨收
1.220
最高
1.280
最低
1.210
成交量
16.41万
成交额
--
52周最高
11.37
52周最低
0.7401
市值
418.29万
市盈率(TTM)
-0.1293
分时
5日
1月
3月
1年
5年

分析师评级

1位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

NSPR 新闻

  • 英国"脱欧"事务大臣:英国下个月将制定欧盟贸易目标
  • 新浪美股.2小时前
  • 离开武汉的500多万人都去了哪里?大数据告诉你
  • 第一财经日报.2小时前
  • iPhone12仅有5G一个卖点?销量难以回暖
  • 新浪财经-自媒体综合.3小时前
  • 确诊3例后 法国华人社区取消多场春节活动
  • 观察者网.4小时前

更多

所属板块

医疗设备、用品及经销
-0.74%
医疗设备和用品
-0.90%

热门股票

名称
价格
涨跌幅

NSPR 简况

InspireMD, Inc. is a medical device company. The Company is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures. Its CGuard carotid embolic prevention system (CGuard EPS) combines its MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. Its MGuard Prime Embolic Protection System (MGuard Prime EPS) is marketed for use in patients with acute coronary syndromes, notably acute myocardial infarction (heart attack) and saphenous vein graft coronary interventions (bypass surgery). It markets and sells MGuard Prime EPS, a bare-metal cobalt-chromium based stent, for the treatment of coronary disease in the European Union. It is also developing a neurovascular flow diverter (NGuard), which is an endovascular device.
展开

Webull提供InspireMD Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。